TORONTO, Oct. 29, 2024 /CNW/ - Neighbourly Pharmacy Inc. ("Neighbourly" or the "Company"), Canada's largest and fastest growing network of independent pharmacies, is pleased to announce the acquisition of 5 additional pharmacies across Canada.
Neighbourly has acquired 5 pharmacies in multiple transactions, with closing in the coming weeks, pending customary regulatory approvals and the satisfaction of customary closing conditions.
"These acquisitions reflect the ongoing execution of our proven and accelerating acquisition strategy. We remain focused on continuing to grow our network of pharmacies and serving more communities across Canada," said Skip Bourdo, Chief Executive Officer of Neighbourly. "These locations are important healthcare providers within their respective communities, and we are delighted to welcome them to the Neighbourly family."
About Neighbourly Pharmacy Inc.
Neighbourly is Canada's largest and fastest growing network of community pharmacies. United by their patient first focus and their role as essential and trusted healthcare hubs within their communities, Neighbourly's pharmacies strive to provide accessible healthcare with a personal touch. Since 2015, Neighbourly has expanded its diversified national footprint across 7 provinces, reinforcing the Company's reputation as the industry's acquirer of choice.
For more information, please visit www.neighbourlypharmacy.ca. For pharmacy owners considering the sale of their pharmacy, please visit www.neighbourlypharmacy.ca/selling-your-pharmacy.
February 13, 2024 January 23, 2024 January 15, 2024 November 13, 2023 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load